Osteoprotegerin (OPG) Levels, Total Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand (Total sRANKL), and OPG/RANKL Ratio in Patients With Rheumatoid Arteritis

Osteoprotegerin (OPG) Levels, Total Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand (Total sRANKL), and OPG/RANKL Ratio in Patients With Rheumatoid Arteritis


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سوسن کلاهی , امیر قربانی حق جو , نادره رشتچی زاده , علیرضا خبازی اسکویی , مهرزاد حاج علیلوی بناب , حمید نوشاد عباسپور

کلمات کلیدی: ACR criteria, OPG, rheumatoid arthritis, sRANKL.

نشریه: 0 , 1 , 2 , 2017

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله سوسن کلاهی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده پزشکی
کد مقاله 61077
عنوان فارسی مقاله Osteoprotegerin (OPG) Levels, Total Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand (Total sRANKL), and OPG/RANKL Ratio in Patients With Rheumatoid Arteritis
عنوان لاتین مقاله Osteoprotegerin (OPG) Levels, Total Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand (Total sRANKL), and OPG/RANKL Ratio in Patients With Rheumatoid Arteritis
ناشر 8
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق) Rheum. Res
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح چهار – SID/Iranmedex/Magiran
آدرس لینک مقاله/ همایش در شبکه اینترنت Webpage: http://rheumres.org

خلاصه مقاله
hide/show

Rheumatoid arthritis (RA) is one of most important collagen vascular diseases. It has an unknown origin. The aim of this study was to evaluate circulating levels of osteoprotegerin (OPG), total soluble receptor activator of nuclear factor-Kappa B ligand (total sRANKL), and RANKL/OPG ratio in patients with RA. Forty-five females with RA, who fulfilled the American college of rheumatology (ACR) criteria for RA were included in this cross-sectional study. The overall disease activity was evaluated by the disease activity score based on 28 joint counts (DAS-28). The OPG and sRANKL were measured by the enzyme-linked immunosorbent assays (ELISA). The levels of C-reactive protein (CRP) were measured by ELISA.We used Pearson’s correlation for our comparisons. There was no statistically significant difference between the levels of CRP, OPG, sRANKL and RANKL/OPG ratio in terms of DAS-28 grades in our patients. No significant correlation was found between the serum levels of OPG and DAS-28 (P= 0.525), duration of the disease (P= 0.884), Z-score of the femur (P= 0.546) and Zscore of the spine (P= 0.492), T-score of the femur (P= 0.137) and T-score of the spine (P= 0.821) in the patient group. No significant correlations were found between sRANKL levels with DAS-28 (0.919), Z-score of the femur (P= 0.971), Z-score of the spine (P= 0.832) and T-score of the femur (P = 0170) in the studied groups. Our study showed that there was no significant correlation between CRP, OPG, sRANKL and RANKL/OPG ratio in DAS-28 grading of our patients. For this reason they will not be used for evaluating disease activity. However, there was a significant difference between case and control groups except for sRANKL (pg/mL)

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سوسن کلاهیاول
امیر قربانی حق جودوم
نادره رشتچی زادهسوم
علیرضا خبازی اسکوییچهارم
مهرزاد حاج علیلوی بنابپنجم
حمید نوشاد عباسپورپنجم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
RR_Volume 2_Issue 1_Pages 23-29.pdf1396/05/05568757دانلود